1832 Asset Management L.P. boosted its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 426.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 771,556 shares of the company’s stock after purchasing an additional 625,048 shares […]
Wallace Capital Management Inc. trimmed its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,306 shares of the company’s stock after selling 200 shares during the quarter. Wallace Capital Management Inc.’s holdings […]
Panagora Asset Management Inc. boosted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 87.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 198,747 shares of the company’s stock after acquiring an additional 92,909 […]
Panagora Asset Management Inc. boosted its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 87.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 198,747 shares of the company’s stock after purchasing an additional 92,909 shares […]
Geode Capital Management LLC increased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 2.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,205,501 shares of the company’s stock after buying an additional 338,077 shares during the period. […]